HRP20130830T1 - A water-in-oil type emulsion for treating a disease of the eye - Google Patents
A water-in-oil type emulsion for treating a disease of the eyeInfo
- Publication number
- HRP20130830T1 HRP20130830T1 HRP20130830AT HRP20130830T HRP20130830T1 HR P20130830 T1 HRP20130830 T1 HR P20130830T1 HR P20130830A T HRP20130830A T HR P20130830AT HR P20130830 T HRP20130830 T HR P20130830T HR P20130830 T1 HRP20130830 T1 HR P20130830T1
- Authority
- HR
- Croatia
- Prior art keywords
- eye
- disease
- treating
- water
- oil type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10175337.4A EP2425814B1 (en) | 2010-09-03 | 2010-09-03 | A water-in-oil type emulsion for treating a disease of the eye |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20130830T1 true HRP20130830T1 (en) | 2013-10-11 |
Family
ID=43662067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20130830AT HRP20130830T1 (en) | 2010-09-03 | 2013-09-05 | A water-in-oil type emulsion for treating a disease of the eye |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2425814B1 (hr) |
CY (1) | CY1114688T1 (hr) |
DK (1) | DK2425814T3 (hr) |
ES (1) | ES2426603T3 (hr) |
HR (1) | HRP20130830T1 (hr) |
PL (1) | PL2425814T3 (hr) |
PT (1) | PT2425814E (hr) |
SI (1) | SI2425814T1 (hr) |
SM (1) | SMT201300101B (hr) |
UA (1) | UA111168C2 (hr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10131910B2 (en) | 2014-07-10 | 2018-11-20 | Stichting Katholieke Universiteit | Antisense oligonucleotides for the treatment of Usher syndrome type 2 |
GB201503408D0 (en) | 2015-02-27 | 2015-04-15 | Proqr Therapeutics N V | Oligonucleotides |
US10760076B2 (en) | 2015-10-05 | 2020-09-01 | Proqr Therapeutics Ii B.V. | Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion |
CN105816423B (zh) * | 2016-03-16 | 2018-07-20 | 福建天泰医药科技有限公司 | 依达拉奉剂型 |
EP3442503B1 (en) * | 2016-04-12 | 2023-03-15 | Capsular Technologies Pty Ltd. | Injectable composition for delivery of a biologically active agent |
US10617707B2 (en) | 2016-04-25 | 2020-04-14 | Proqr Therapeutics Ii B.V. | Oligonucleotides to treat eye disease |
GB201616202D0 (en) | 2016-09-23 | 2016-11-09 | Proqr Therapeutics Ii Bv | Antisense oligonucleotides for the treatment of eye deisease |
WO2018109011A1 (en) | 2016-12-13 | 2018-06-21 | Stichting Katholieke Universiteit | Antisense oligonucleotides for the treatment of stargardt disease |
WO2020015959A1 (en) | 2018-07-19 | 2020-01-23 | Stichting Katholieke Universiteit | Antisense oligonucleotides rescue aberrant splicing of abca4. |
EA202191469A1 (ru) | 2018-12-04 | 2021-10-19 | Стихтинг Католике Университет | Восстановление посредством антисмысловых олигонуклеотидов abca4 с аберрантным сплайсингом |
CA3126371A1 (en) | 2019-01-28 | 2020-08-06 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for the treatment of leber's congenital amaurosis |
CA3136172A1 (en) | 2019-04-18 | 2020-10-22 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for the treatment of usher syndrome |
CN110090225B (zh) * | 2019-04-19 | 2021-07-16 | 济南康和医药科技有限公司 | 一种依达拉奉氯化钠注射液及其制备方法 |
US20220290154A1 (en) | 2019-08-08 | 2022-09-15 | Stichting Radboud Universitair Medisch Centrum | Antisense oligonucleotides rescue aberrant splicing of ABCA4 |
IT201900019190A1 (it) | 2019-10-17 | 2021-04-17 | Univ Politecnica Delle Marche | Derivato dell’epigallocatechina gallato |
US20230134677A1 (en) | 2020-03-04 | 2023-05-04 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for use in the treatment of usher syndrome |
WO2022090256A1 (en) | 2020-10-26 | 2022-05-05 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for the treatment of stargardt disease |
WO2024074670A1 (en) | 2022-10-06 | 2024-04-11 | Stichting Radboud Universitair Medisch Centrum | Antisense oligonucleotides for treatment of usher 2a. exon 68 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1318539B1 (it) | 2000-05-26 | 2003-08-27 | Italfarmaco Spa | Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente |
US6417237B1 (en) * | 2000-06-08 | 2002-07-09 | The Board Of Trustees Of The University Of Illinois | Macromolecular drug complexes and compositions containing the same |
US7691408B2 (en) * | 2002-03-12 | 2010-04-06 | Ethypharm | Composition having gelling properties for the prolonged delivery of bioactive substances |
EP1867323A1 (en) * | 2006-06-13 | 2007-12-19 | Farmatron Ltd. | Pharmaceutical compositions with biological barriers permeation enhancing properties |
US9125807B2 (en) | 2007-07-09 | 2015-09-08 | Incept Llc | Adhesive hydrogels for ophthalmic drug delivery |
RU2505311C2 (ru) | 2007-10-02 | 2014-01-27 | Потентия Фармасьютикалз, Инк. | Пролонгированная доставка аналогов компстатина из гелей |
-
2010
- 2010-09-03 ES ES10175337T patent/ES2426603T3/es active Active
- 2010-09-03 SI SI201030338T patent/SI2425814T1/sl unknown
- 2010-09-03 DK DK10175337.4T patent/DK2425814T3/da active
- 2010-09-03 PT PT101753374T patent/PT2425814E/pt unknown
- 2010-09-03 PL PL10175337T patent/PL2425814T3/pl unknown
- 2010-09-03 EP EP10175337.4A patent/EP2425814B1/en active Active
-
2011
- 2011-02-09 UA UAA201302734A patent/UA111168C2/uk unknown
-
2013
- 2013-09-04 CY CY20131100763T patent/CY1114688T1/el unknown
- 2013-09-05 HR HRP20130830AT patent/HRP20130830T1/hr unknown
- 2013-09-18 SM SM201300101T patent/SMT201300101B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2425814A1 (en) | 2012-03-07 |
ES2426603T3 (es) | 2013-10-24 |
UA111168C2 (uk) | 2016-04-11 |
SI2425814T1 (sl) | 2013-10-30 |
DK2425814T3 (da) | 2013-09-08 |
CY1114688T1 (el) | 2016-10-05 |
SMT201300101B (it) | 2013-11-08 |
PT2425814E (pt) | 2013-09-02 |
PL2425814T3 (pl) | 2013-11-29 |
EP2425814B1 (en) | 2013-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20130830T1 (en) | A water-in-oil type emulsion for treating a disease of the eye | |
HK1258775A1 (zh) | 油包水型乳化防曬化妝品 | |
HK1186660A1 (en) | A water-in-oil type emulsion for treating a disease of the eye | |
HK1201196A1 (en) | Treatment of ocular disease | |
HK1196550A1 (en) | Water-in-oil emulsion sunscreen cosmetic | |
HK1169320A1 (zh) | 眼用乳劑 | |
EP2790622A4 (en) | LITHOTRITIC OCULAR TREATMENT | |
EP2760359A4 (en) | METHOD FOR TREATING EYE STATES | |
EP2753275A4 (en) | METHODS OF TREATING OCULAR CONDITIONS | |
EP2559426A4 (en) | WATER IN OIL EMULSION COMPOUND | |
PL2575881T3 (pl) | Przeciwciała swoiste wobec CD160 do leczenia zaburzeń oczu związanych z angiogenezą | |
HK1184066A1 (zh) | 油包水型乳化化妝品 | |
PL2560616T3 (pl) | Emulsja naśladująca łzy | |
EP2680842A4 (en) | METHOD FOR THE TREATMENT OF A DISEASE OR A SENSE OF THE CENTRAL NERVOUS SYSTEM | |
PT2959903T (pt) | Medicamento para tratar doença ocular | |
HK1207569A1 (en) | Water-in-oil emulsion cosmetic | |
IL230960A0 (en) | A device for the treatment of eye disease | |
EP2692333A4 (en) | COSMETICS WITH WATER IN OIL EMULSION | |
EP2717887A4 (en) | METHOD FOR TREATING OR PREVENTING TRANSPLANT DISCHARGE | |
PT2709577T (pt) | Aparelho para a observação ou para o tratamento de um olho humano | |
IL230959B (en) | A device for the treatment of eye disease | |
EP2870971A4 (en) | MEDICAMENT FOR THE PREVENTION / TREATMENT OF AN OCULAR DISEASE | |
EP2692329A4 (en) | COSMETIC WATER IN OIL EMULSION COMPOSITION | |
ZA201407215B (en) | Method for emulsion treatment | |
PL2768527T3 (pl) | Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1 |